Native Joint Propionibacterium Septic Arthritis

Total Page:16

File Type:pdf, Size:1020Kb

Native Joint Propionibacterium Septic Arthritis Infectious Disease Reports 2017; volume 9:7185 Native joint Propionibacterium septic arthritis Introduction Correspondence: Thomas Taylor, White River Propionibacterium species are anaer- Junction Veterans Affairs Regional Medical obes associated with normal skin flora, and Center, 215 N Main St. White River Jct. VT Thomas Taylor,1,2 Marcus Coe,3,4 05009, USA, cultures may be dismissed as contaminants. Ana Mata-Fink,5 Richard Zuckerman1,4 E-mail: [email protected] They are a less virulent but now well recog- 1 Department of Medicine, Geisel nized cause of infection following shoulder Key words: Propionibacterium, septic arthri- Medical School at Dartmouth, Hanover, surgery; and infection of orthopedic hard- tis, osteoarthritis, anaerobe infection. NH; 2White River Junction VA Regional ware, vertebral osteomyelitis, endovascular Medical Center, VT; 3Department of devices, and cerebrospinal shunts. The Contributions: the authors contributed equally. Orthopedic Surgery, Geisel Medical course is indolent, often without typical Conflict of interest: the authors declare no School at Dartmouth, Hanover, NH; signs or symptoms of infection. Delayed anaerobic growth may contribute to falsely potential conflict of interest. The views 4Dartmouth-Hitchcock Medical Center, negative cultures, late diagnosis, and poor expressed herein do not necessarily represent Lebanon, NH; 5Department of outcomes. Delayed recognition of the views of the Department of Veterans Affairs or the US Orthopedics and Rehabilitation, Yale Propionibacterium septic arthritis follow- Government. Physician’s Building, New Haven, CT, ing shoulder arthroplasty has been well doc- USA 1 umented, but native joint septic arthritis Received for publication: 17 April 2017. may be under recognized, undiagnosed, and Revision received: 15 June 2017. consequently falsely attributed to orthope- Accepted for publication: 24 June 2017. dic surgery. Abstract This work is licensed under a Creative Propionibacterium species are associat- Commons Attribution-NonCommercial 4.0 ed with normal skin flora and cultures may Materials and Methods International License (CC BY-NC 4.0). be dismissed as contaminants. They are We present three cases of only©Copyright T. Taylor et al., 2017 increasingly recognized as a cause of septic Propionibacterium acnes septic arthritis in Licensee PAGEPress, Italy arthritis following shoulder arthroplasty and native joints, which exemplify chronic and Infectious Disease Reports 2017; 9:7185 arthrotomy. We identified three cases of atypical characteristics. The two septic knee doi:10.4081/idr.2017.7185 Propionibacterium septic arthritis in native joints were falsely considered to representuse joints mimicking atypical osteoarthritis and osteoarthritis. We did a search of the litera- (PVNS), other synovial tumor, and extent of review the literature, clinical course, and ture using PubMed citation septic arthritis treatment of 18 cases. Two cases of osteoarthritis. Synovial biopsies were nega- Propionibacterium for cases, and Clinical tive for PVNS, and cultures again grew P. Propionibacterium acne in native knee Key citation Propionibacterium for case acnes. The diagnosis of septic arthritis was joints and one in a sternoclavicular joint are series. Fifteen cases laid out in Table 1 confirmed by synovial pathology and he described. A literature search for alongside our case numbers 1-3 demon- received 6 weeks of IV ceftriaxone and Propionibacterium septic arthritis was per- strate similar presentations and outcomes arthrocentesis with negative cultures. He formed. Clinical course, treatment, and out- (see supplemental references for cases suffered residual painful ambulation and come are reviewed for all cases. Our three reviewed from the literature). cases were combined with 15 cases from post infectious synovitis with recurrent ster- the literature. Fourteen cases showed few ile effusions. He will require future total joint arthroplasty, if cultures remain nega- signs of acute infection, slow culture commercialCase Report #1 growth, and delayed diagnosis. In 3 cases tive and post infectious synovitis subsides. A 56 year-old healthy male with moder- an early culture was dismissed as a contam- ate osteoarthritis of his right knee noted inant. Six cases were reported as caused by swelling and pain in the knee after a night recent arthrocentesis. Fifteen cases were Case Report #2 Non out with friends. Four years prior he had cured with antibiotics, although 5 of these repair of his right knee anterior cruciate lig- A 44 year-old healthy male presented 15 also required surgical intervention. Two ament, without residual hardware or staples. with tricompartment osteoarthritis. In 2001 patients were diagnosed while undergoing He suspected minor trauma superimposed he sustained a patellar rupture that was surgery for osteoarthritis. Four patients on his osteoarthritis and nursed the knee repaired primarily. He subsequently had a required arthroplasty and two of our over 4 months. He presented to Arthritis revision of the repair with xenograft. He patients will require arthroplasty for good Clinic with a large knee effusion for consid- had persistent knee pain and was treated functional results. Propionibacterium as a eration of steroid injection. Arthrocentesis with hyaluronate derivatives, cortisone cause of septic arthritis in native joints yielded 60cc of mildly inflammatory and injections, and multiple knee arthroscopies. demonstrates few signs of acute infection, bloody synovial fluid. Analysis revealed no He presented to the Orthopedic Surgery presents with prolonged course, and is often crystals, many old RBCs, 2169 cells (30% clinic with a joint effusion in August 2014 misdiagnosed or unsuspected. Anaerobic neutrophils, 40% macrophages, 30% lym- to pursue knee arthroplasty. At surgery in growth may be delayed or missed altogeth- phocytes). Culture became positive on the December 2014 the synovium was noted to er, and outcomes are consequently poor. 5th day with P. acnes which was considered be discolored with bloody, brown tinged Consider Propionibacterium septic arthritis to be a skin contaminant; given the long synovial fluid and yellow-brown colored in atypical osteoarthritis prior to arthroplas- duration of symptoms, low cell count, and cartilage with irregularities, fissuring, and ty. minimal pain. No steroid injections were full-thickness loss. Synovial samples were given, and he was referred for arthroscopy taken and the knee was irrigated and closed to assess for polyvillonodular synovitis without arthroplasty. Intra-operative syn- [Infectious Disease Reports 2017; 9:7185] [page 87] Case Report ovial fluid cultures were negative, but syn- ovial tissue culture became positive on the 7th day with P. acnes. He was started on Ceftriaxone and returned to the operating room for a synovectomy. He completed a 6- week course of Ceftriaxone with cure, but prior poor functional status has not improved. Case Report #3 A 60 year-old male with medical comorbidities including obesity, alcohol abuse, and cirrhosis developed pain and swelling at the left sternoclavicular joint in September 2014, while working as a mason, without skin break or direct trauma. He was prescribed prednisone and cyclobenzaprine, but a week later developed fever and was admitted to hospital and given a short course of antibiotics for possible pneumo- nia. CXR was suspicious for a lung nodule. CT and PET scan showed a metabolically active lung mass adjacent to the sternoclav- icular joint and manubrium. He left the hos- only pital without complete evaluation. In November 2014 a follow-up CT scan noted improvement in lung findings, but progres- sive erosion of the SC joint. In February use 2015 he returned to the admitting hospital where a CT guided biopsy revealed mild fibrosis and lymphoplasmacytic infiltrate, and culture grew P. acnes from thyoglyco- late broth only. He remained afebrile; CRP was 10.3. Given the chronic course and pos- sibility of skin contamination, a surgical biopsy was performed and confirmed P. acnes osteomyelitis with 3 of 4 positive tis- sue cultures. He was treated with 6 weeks of IV ceftriaxone followed by 3 weeks of PO moxifloxacin, with improvement in pain, commercial swelling, and function. Results Non Insidious presenting courses occurred in 14 cases, most with predisposing trauma or arthritis, frequently osteoarthritis (OA). Multiple organisms isolated. There were 4 acute presentations (cases 9, µ 10, 11, 12), all with likely unrecognized insidious courses. Case 9 presented with a OA 6 months None None Ceftriaxone Cure Good Cure Ceftriaxone None None 6 months OA hand abscess, acute Propionibacterium sep- § Burns osteomyelitis years Bone resection None Vancomycin more bone resection Failure epithelioid sarcoma Poor sarcoma epithelioid Failure resection bone more None Vancomycin resection Bone years osteomyelitis Burns Trauma years Bone resection None Clindamycin arthrotomy Cure Poor Cure arthrotomy Clindamycin None resection Bone years Trauma OA 4 months ACL repair None Ceftriaxone arthroscopy Cure Poor Cure arthroscopy Ceftriaxone None repair ACL 4 months OA Hand abscess, sepsis 2 weeks None None Clindamycin Cure Good Cure Clindamycin None None 2 weeks sepsis abscess, Hand µ µ µ µ sis, and likely concomitant seeding of an § septic arthritis in joints. native osteoarthritic knee joint. This case was one of 3 polymicrobial infections (noted by µ). In the other two polymicrobial cases, multi- ple organisms were isolated following pro- Initial culture discounted
Recommended publications
  • Resection Arthroplasty for Failed Shoulder Arthroplasty
    J Shoulder Elbow Surg (2013) 22, 247-252 www.elsevier.com/locate/ymse Resection arthroplasty for failed shoulder arthroplasty Stephanie J. Muh, MDa, Jonathan J. Streit, MDb, Christopher J. Lenarz, MDa, Christopher McCrum, BSc, John Paul Wanner, BSa, Yousef Shishani, MDa, Claudio Moraga, MDd, Robert J. Nowinski, DOe, T. Bradley Edwards, MDf, Jon J.P. Warner, MDg, Gilles Walch, MDh, Reuben Gobezie, MDi,* aCase Shoulder and Elbow Service, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, OH, USA bDepartment of Orthopaedics, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, OH, USA cCase Western Reserve University School of Medicine, Cleveland, OH, USA dDepartment of Orthopedic Surgery, Clinica Alemana Santiago, Santiago, Chile eOrthoNeuro, New Albany, OH, USA fFondren Orthopedic Group, Houston, TX, USA gHarvard Shoulder Service, Massachusetts General Hospital, Boston, MA, USA hCentre Orthopedique Santy, Shoulder Unit, Lyon, France iThe Cleveland Shoulder Institute, University Hospitals of Cleveland, Cleveland, OH, USA Background: As shoulder arthroplasty becomes more common, the number of failed arthroplasties requiring revision is expected to increase. When revision arthroplasty is not feasible, resection arthroplasty has been used in an attempt to restore function and relieve pain. Although outcomes data for resection arthroplasty exist, studies comparing the outcomes after the removal of different primary shoulder arthro- plasties have been limited. Materials and methods: This was a retrospective multicenter review of 26 patients who underwent resection arthroplasty for failure of a primary arthroplasty at a mean follow-up of 41.8 months (range, 12-130 months). Resection arthroplasty was performed for 6 failed total shoulder arthroplasties (TSAs), 7 failed hemiarthro- plasties, and 13 failed reverse TSAs.
    [Show full text]
  • Managing and Recognizing Complications After Treatment of Acromioclavicular Joint Repair Or Reconstruction
    See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/272096166 Managing and recognizing complications after treatment of acromioclavicular joint repair or reconstruction Article in Current Reviews in Musculoskeletal Medicine · February 2015 DOI: 10.1007/s12178-014-9255-6 · Source: PubMed CITATION READS 1 182 6 authors, including: Patrick A Smith Matthew J Smith University of Missouri University of Missouri 28 PUBLICATIONS 255 CITATIONS 16 PUBLICATIONS 115 CITATIONS SEE PROFILE SEE PROFILE Seth L Sherman David L Flood University of Missouri University of Missouri 69 PUBLICATIONS 1,378 CITATIONS 3 PUBLICATIONS 21 CITATIONS SEE PROFILE SEE PROFILE Some of the authors of this publication are also working on these related projects: Commentary & Perspective Total Hip Arthroplasty View project Drug Reaction with Eosinophilia and Systemic Symptoms Associated with a Vancomycin-Impregnated Spacer View project All content following this page was uploaded by Xinning Li on 15 February 2015. The user has requested enhancement of the downloaded file. Curr Rev Musculoskelet Med DOI 10.1007/s12178-014-9255-6 SHOULDER SURGERY: COMPLICATIONS (X LI, SECTION EDITOR) Managing and recognizing complications after treatment of acromioclavicular joint repair or reconstruction Richard Ma & Patrick A. Smith & Matthew J. Smith & Seth L. Sherman & David Flood & Xinning Li # Springer Science+Business Media New York 2015 Abstract Complications of the acromioclavicular joint inju- Introduction ries can occur as a result of the injury itself, conservative management, or surgical treatment. Fortunately, the majority Injuries to the acromioclavicular (AC) joint are common, par- of acromioclavicular surgeries utilizing modern techniques ticularly among the young and active population.
    [Show full text]
  • Functional Outcome Oxford Shoulder Score After Modified Weaver Dunn Technique Reconstruction in Patients with Acromioclavicular Injuries
    International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 0974-4304, ISSN(Online): 2455-9563 Vol.12, No.03, pp 71-74, 2019 Functional Outcome Oxford Shoulder Score after Modified Weaver Dunn Technique Reconstruction in Patients with Acromioclavicular Injuries Hendra1*, Nino Nasution2, Andriandi3, Asnan Lelo4 1Resident of Orthopaedic and Traumatology, Faculty of Medicine University of Sumatera Utara/ Haji Adam Malik Hospital-Medan, Indonesia 2Consultant of Orthopaedic and Traumatology, Faculty of Medicine University of Sumatera Utara/ Haji Adam Malik Hospital-Medan, Indonesia 3Consultant of Orthopaedic and Traumatology, Faculty of Medicine University of Sumatera Utara/ Haji Adam Malik Hospital-Medan, Indonesia 4Statistic Consultant of Orthopaedic and Traumatology, Faculty of Medicine University of Sumatera Utara/ Haji Adam Malik Hospital-Medan, Indonesia Abstract : Objective : The aim of this study was to compare the clinical outcome of Oxford Shoulder Score in patients with acromioclavicular injuries that were operated with Modified Weaver Dunn Technique Reconstruction compared with the healthy side. Material And Methods : A total of 8 patients with acromioclavicular injuries from 2011 until 2019 that were included into the study that were treated with Modified Weaver Dunn Technique. Age, gender, range of motion and OSS score that was followed for minimum 6 months after surgery (Oxford Shoulder Score [OSS]) were recorded. Results : Patients' gender characteristics totalled three females (3) and five males (5). There weren’t
    [Show full text]
  • 2017 American College of Rheumatology/American Association
    Arthritis Care & Research Vol. 69, No. 8, August 2017, pp 1111–1124 DOI 10.1002/acr.23274 VC 2017, American College of Rheumatology SPECIAL ARTICLE 2017 American College of Rheumatology/ American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty SUSAN M. GOODMAN,1 BRYAN SPRINGER,2 GORDON GUYATT,3 MATTHEW P. ABDEL,4 VINOD DASA,5 MICHAEL GEORGE,6 ORA GEWURZ-SINGER,7 JON T. GILES,8 BEVERLY JOHNSON,9 STEVE LEE,10 LISA A. MANDL,1 MICHAEL A. MONT,11 PETER SCULCO,1 SCOTT SPORER,12 LOUIS STRYKER,13 MARAT TURGUNBAEV,14 BARRY BRAUSE,1 ANTONIA F. CHEN,15 JEREMY GILILLAND,16 MARK GOODMAN,17 ARLENE HURLEY-ROSENBLATT,18 KYRIAKOS KIROU,1 ELENA LOSINA,19 RONALD MacKENZIE,1 KALEB MICHAUD,20 TED MIKULS,21 LINDA RUSSELL,1 22 14 23 17 ALEXANDER SAH, AMY S. MILLER, JASVINDER A. SINGH, AND ADOLPH YATES Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to the recommendations within this guideline to be volun- tary, with the ultimate determination regarding their application to be made by the physician in light of each patient’s individual circumstances. Guidelines and recommendations are intended to promote benefi- cial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed and endorsed by the ACR are subject to periodic revision as warranted by the evolution of medi- cal knowledge, technology, and practice.
    [Show full text]
  • WARD-DOCUMENT-2020.Pdf (1.324Mb)
    3D Printing Impact on the Orthopedic Shoulder Replacement Global Supply Chain The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Ward, Abner. 2020. 3D Printing Impact on the Orthopedic Shoulder Replacement Global Supply Chain. Master's thesis, Harvard Extension School. Citable link https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37365004 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA 3D Printing Impact on the Orthopedic Shoulder Replacement Global Supply Chain Abner M. Ward, MD, MBA, FACS, FAAOS A Thesis in the Field of Biotechnology Management for the Degree of Master of Liberal Arts in Extension Studies Harvard University May 2020 Copyright 2020 [Abner Ward] Abstract The goal of this work was to investigate a novel new technology being used to improve total shoulder replacements in patients with difficult to treat anatomy. The new technology is the use of three-dimensional (3D) implant creations that can be tailored to a patient’s specific shoulder defects as opposed to shelf, standard size implants. The project will help provide management direction to improve the efficiency in the global supply system so that surgeons in various parts of the world may have access to surgical components in the shortest time without significant delay. The study findings were that hindrances to 3D adoption for just-in-time surgical usage primarily include difficulties with sterilization and lack of a global validation metric when performed at multiple international centers, as opposed to one location in a single country.
    [Show full text]
  • Evaluation of the Painful Shoulder
    Evaluation of the Painful Shoulder J. Lindsay Quade, MD Clinical Instructor Internal Medicine/Pediatrics, Sports Medicine Michigan Medicine Objectives • To improve physician comfort with obtaining relevant history in the evaluation of the painful shoulder • To improve physician comfort with physical examination of the shoulder, including special testing • To improve physician comfort with diagnosis and management of common causes of shoulder pain The Shoulder • Shoulder pain is common in the primary care setting, responsible for 16% of all musculoskeletal complaints. • Taking a good history can help tailor the physical exam and narrow the diagnosis. • Knowledge of common shoulder disorders is important as they can often be treated with conservative measures and without referral to a subspecialist. Shoulder Anatomy Shoulder Anatomy Shoulder Anatomy Shoulder Anatomy MSK Shoulder Pain Differential • Articular Causes • Periarticular Causes • Glenohumeral (GH) and acromoclavicular • Chronic impingement and rotator cuff (AC) arthritis tendinitis • Ligamentous and labral lesions • Bicep tendinitis • GH and AC joint instability • Rotator cuff and long biceps tendon tears • Osseus: fracture, osteonecrosis, neoplasm, • Subacromial bursitis infection • Adhesive capsulitis Taking Your History • Age • Duration • Grinding or clicking • Hand dominance • Radiation • Weakness • Occupation • Aggravating/relieving • Numbness/tingling factors • Sports/physical activities • Pain • Night pain • Trauma • Effect on shoulder • Onset function • Location • Stiffness/restriction
    [Show full text]
  • Synovial Fluidfluid 11
    LWBK461-c11_p253-262.qxd 11/18/09 6:04 PM Page 253 Aptara Inc CHAPTER SynovialSynovial FluidFluid 11 Key Terms ANTINUCLEAR ANTIBODY ARTHROCENTESIS BULGE TEST CRYSTAL-INDUCED ARTHRITIS GROUND PEPPER HYALURONATE MUCIN OCHRONOTIC SHARDS RHEUMATOID ARTHRITIS (RA) RHEUMATOID FACTOR (RF) RICE BODIES ROPE’S TEST SEPTIC ARTHRITIS Learning Objectives SYNOVIAL SYSTEMIC LUPUS ERYTHEMATOSUS 1. Define synovial. VISCOSITY 2. Describe the formation and function of synovial fluid. 3. Explain the collection and handling of synovial fluid. 4. Describe the appearance of normal and abnormal synovial fluids. 5. Correlate the appearance of synovial fluid with possible cause. 6. Interpret laboratory tests on synovial fluid. 7. Suggest further testing for synovial fluid, based on preliminary results. 8. List the four classes or categories of joint disease. 9. Correlate synovial fluid analyses with their representative disease classification. 253 LWBK461-c11_p253-262.qxd 11/18/09 6:04 PM Page 254 Aptara Inc 254 Graff’s Textbook of Routine Urinalysis and Body Fluids oint fluid is called synovial fluid because of its resem- blance to egg white. It is a viscous, mucinous substance Jthat lubricates most joints. Analysis of synovial fluid is important in the diagnosis of joint disease. Aspiration of joint fluid is indicated for any patient with a joint effusion or inflamed joints. Aspiration of asymptomatic joints is beneficial for patients with gout and pseudogout as these fluids may still contain crystals.1 Evaluation of physical, chemical, and microscopic characteristics of synovial fluid comprise routine analysis. This chapter includes an overview of the composition and function of synovial fluid, and laboratory procedures and their interpretations.
    [Show full text]
  • Evicore Musculoskeletal Imaging Guidelines
    CLINICAL GUIDELINES Musculoskeletal Imaging Policy Version 2.1 Effective October 1, 2020 eviCore healthcare Clinical Decision Support Tool Diagnostic Strategies: This tool addresses common symptoms and symptom complexes. Imaging requests for individuals with atypical symptoms or clinical presentations that are not specifically addressed will require physician review. Consultation with the referring physician, specialist and/or individual’s Primary Care Physician (PCP) may provide additional insight. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five digit codes, nomenclature and other data are copyright 2020 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in the CPT® book. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. © 2020 eviCore healthcare. All rights reserved. Musculoskeletal Imaging Guidelines V2.1 Musculoskeletal Imaging Guidelines Procedure Codes associated with Musculoskeletal Imaging 3 MS-1: General Guidelines 5 MS-2: Imaging Techniques 8 MS-3: 3D Rendering 12 MS-4: Avascular Necrosis (AVN)/Osteonecrosis 13 MS-5: Fractures 16 MS-6: Foreign Body 20 MS-7: Ganglion Cysts 22 MS-8: Gout/Calcium Pyrophosphate Deposition Disease (CPPD)/ Pseudogout/Chondrocalcinosis 24 MS-9: Infection/Osteomyelitis 26 MS-10: Soft Tissue Mass or Lesion of Bone 29 MS-11: Muscle/Tendon Unit
    [Show full text]
  • ICD~10~PCS Complete Code Set Procedural Coding System Sample
    ICD~10~PCS Complete Code Set Procedural Coding System Sample Table.of.Contents Preface....................................................................................00 Mouth and Throat ............................................................................. 00 Introducton...........................................................................00 Gastrointestinal System .................................................................. 00 Hepatobiliary System and Pancreas ........................................... 00 What is ICD-10-PCS? ........................................................................ 00 Endocrine System ............................................................................. 00 ICD-10-PCS Code Structure ........................................................... 00 Skin and Breast .................................................................................. 00 ICD-10-PCS Design ........................................................................... 00 Subcutaneous Tissue and Fascia ................................................. 00 ICD-10-PCS Additional Characteristics ...................................... 00 Muscles ................................................................................................. 00 ICD-10-PCS Applications ................................................................ 00 Tendons ................................................................................................ 00 Understandng.Root.Operatons..........................................00
    [Show full text]
  • CPT® Procedural Coding 110 L with Areportoftheprocedure
    20610-20611 2017 Illustrated Coding and Billing Expert for Orthopedics Lower 20610-20611 ICD-9-CM Diagnostic Codes M16.7 Other unilateral secondary 711.05 Pyogenic arthritis involving pelvic osteoarthritis of hip 20610 Arthrocentesis, aspiration and/or region and thigh M17.0 Bilateral primary osteoarthritis of injection, major joint or bursa (eg, 711.06 Pyogenic arthritis involving lower leg knee shoulder, hip, knee, subacromial 713.5 Arthropathy associated with ⇄ M17.11 Unilateral primary osteoarthritis, right bursa); without ultrasound guidance neurological disorders knee 20611 Arthrocentesis, aspiration and/or 714.0 Rheumatoid arthritis ⇄ M17.12 Unilateral primary osteoarthritis, left knee injection, major joint or bursa (eg, 715.15 Osteoarthrosis, localized, primary, pelvic region and thigh M17.2 Bilateral post-traumatic osteoarthritis shoulder, hip, knee, subacromial 715.16 Osteoarthrosis, localized, primary, of knee bursa); with ultrasound guidance, with lower leg M17.5 Other unilateral secondary permanent recording and reporting 715.25 Osteoarthrosis, localized, secondary, osteoarthritis of knee (Do not report 20610, 20611 in pelvic region and thigh ⇄ M1A.051 Idiopathic chronic gout, right hip conjunction with 27370, 76942) 715.26 Osteoarthrosis, localized, secondary, ⇄ M1A.062 Idiopathic chronic gout, left knee (If fluoroscopic, CT, or MRI guidance is lower leg ⇄ M25.052 Hemarthrosis, left hip ⇄ M25.061 Hemarthrosis, right knee performed, see 77002, 77012, 77021) 715.35 Osteoarthrosis, localized, not specified whether primary
    [Show full text]
  • Hip Replacement/Arthroplasty Effective March 15, 2020
    Cigna Medical Coverage Policies – Musculoskeletal Hip Replacement/Arthroplasty Effective March 15, 2020 Instructions for use The following coverage policy applies to health benefit plans administered by Cigna. Coverage policies are intended to provide guidance in interpreting certain standard Cigna benefit plans and are used by medical directors and other health care professionals in making medical necessity and other coverage determinations. Please note the terms of a customer’s particular benefit plan document may differ significantly from the standard benefit plans upon which these coverage policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a coverage policy. In the event of a conflict, a customer’s benefit plan document always supersedes the information in the coverage policy. In the absence of federal or state coverage mandates, benefits are ultimately determined by the terms of the applicable benefit plan document. Coverage determinations in each specific instance require consideration of: 1. The terms of the applicable benefit plan document in effect on the date of service 2. Any applicable laws and regulations 3. Any relevant collateral source materials including coverage policies 4. The specific facts of the particular situation Coverage policies relate exclusively to the administration of health benefit plans. Coverage policies are not recommendations for treatment and should never be used as treatment guidelines. This evidence-based medical coverage policy has been developed by eviCore, Inc. Some information in this coverage policy may not apply to all benefit plans administered by Cigna. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA).
    [Show full text]
  • Clinical Guidelines
    CLINICAL GUIDELINES Joint Services Guidelines Version 1.0.2019 Clinical guidelines for medical necessity review of comprehensive musculoskeletal management services. © 2019 eviCore healthcare. All rights reserved. Regence: Comprehensive Musculoskeletal Management Guidelines V1.0.2019 Large Joint Services CMM-311: Knee Replacement/Arthroplasty 3 CMM-312: Knee Surgery-Arthroscopic and Open Procedures 14 CMM-313: Hip Replacement/Arthroplasty 35 CMM-314: Hip Surgery-Arthroscopic and Open Procedures 46 CMM-315: Shoulder Surgery-Arthroscopic and Open Procedures 47 CMM-318: Shoulder Arthroplasty/ Replacement/ Resurfacing/ Revision/ Arthrodesis 62 ______________________________________________________________________________________________________ © 2019 eviCore healthcare. All Rights Reserved. Page 2 of 69 400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924 www.eviCore.com Regence: Comprehensive Musculoskeletal Management Guidelines V1.0.2019 CMM-311: Knee Replacement/Arthroplasty CMM-311.1: Definition 4 CMM-311.2: General Guidelines 5 CMM-311.3: Indications and Non-Indications 5 CMM-311.4 Experimental, Investigational, or Unproven 9 CMM-311.5: Procedure (CPT®) Codes 10 CMM-311.6: References 10 ______________________________________________________________________________________________________ © 2019 eviCore healthcare. All Rights Reserved. Page 3 of 69 400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924 www.eviCore.com Regence: Comprehensive Musculoskeletal Management Guidelines V1.0.2019 CMM-311.1: Definition
    [Show full text]